航空医学実験隊発刊「パイロットの服薬に関する研究成果報告」

抄録

Preventing incapacitation of aviator during flight is one of major missions in aerospace medicine. To prevent incapacitation and maintain health status of pilots, airline companies and Air Forces develop manuals and guidelines for aeromedical examination or use of medications. Though guidelines for aeromedical examinations and major diseases are defined in detail, there are no detailed guidelines about medications in chronic disease or common disease. Since early 1990s, as life-style related diseases increase, Aeromedical Laboratory haｓ received numerous inquiries and cases to be reviewed in aeromedical council. To standardize aeromedical decision making and share information, Pharmacochemistry Section, Second Division of Aeromedical Laboratory published “Working Papers for aeromedical decision on medicated aviators” in 1999. This paper include following contents about common disease and medications. (1) Notice in initial medication (2) Aeromedical decision Cases to be avoided if possible, to be evaluated for returning flying duty during medications, to be allowed flying with medications (3) Effects for psychomotor activities (4) Cases of aviation accidents (5) Cases of aeromedical council (6) Reports of side effect In 2014 issue, we classify the risk of medications for aeromedical missions. We also have a planning to distribute digital issues in the same time. Points of considerations are academic reason and application for practical operations.